Galmed Pharmaceuticals (GLMD) has released an update.
Galmed Pharmaceuticals is inviting shareholders to a Special General Meeting on October 14, 2024, to vote on increasing the company’s authorized share capital and amending its Articles of Association accordingly. The company’s board is recommending a vote in favor of the proposal, which aims to enable the company to raise capital and pursue future business opportunities. Shareholders are encouraged to attend the meeting or submit their proxy votes in advance to ensure their shares are represented.
For further insights into GLMD stock, check out TipRanks’ Stock Analysis page.
